NAMS NewAmsterdam Pharma Company N.V.
$22.36
NewAmsterdam Pharma Company N.V. (NAMS) SEC Filings
Everything NAMS has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.
| Date | Form | Filing |
|---|---|---|
| 4 | View filing | |
| 144/A | View filing | |
| 4 | View filing | |
| 144 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing |
Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.